Foetal Responses to Thromboxane Receptor Blockade
Author Information
Author(s): B.A. Meyer, J.E. Dickinson, S.W. Walsh, V.M. Parisi
Primary Institution: University of Texas Medical School, Houston
Hypothesis
Foetal administration of SQ-29,548 would prevent foeto-placental vasoconstriction produced by the thromboxane mimic U46619.
Conclusion
Foetal administration of SQ-29,548 blocks the vascular response to thromboxane but can lead to reduced umbilical-placental blood flow and deteriorating foetal acid-base status.
Supporting Evidence
- Foetal heart rate decreased significantly in response to U46619.
- Umbilical-placental blood flow was significantly reduced after prolonged SQ infusion.
- Foetal acid-base status deteriorated with prolonged SQ infusion.
Takeaway
The study tested a drug to see if it could help babies in the womb by stopping blood vessels from tightening, but it found that the drug could also cause problems with blood flow.
Methodology
Nine pregnant ewes were studied, and various physiological parameters were measured during the administration of SQ-29,548 and U46619.
Limitations
The small sample size may limit the generalizability of the findings.
Participant Demographics
Pregnant western-bred ewes, gestation between 126 and 132 days.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website